Review



cb2 inverse agonist sr 144528  (Cayman Chemical)


Bioz Verified Symbol Cayman Chemical is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cayman Chemical cb2 inverse agonist sr 144528
    Cb2 Inverse Agonist Sr 144528, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cb2+inverse+agonist+sr+144528/rabbit+anti+cb2r/pm40221089-196-23-30
    Average 90 stars, based on 1 article reviews
    cb2 inverse agonist sr 144528 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: The endocannabinoid system drives eosinophil infiltration during eosinophilic esophagitis.
    Article Snippet: For the duration of the experimental protocol, mice were treated with an MGL inhibitor (JZL 398 184, 16 mg/kg/d, Cayman) or with a CB2 inverse agonist (SR 144528, 10 mg/kg/d, Cayman).



    Similar Products

    cb2 inverse agonist sr 144528  (Cayman Chemical)
    90
    Cayman Chemical cb2 inverse agonist sr 144528
    Cb2 Inverse Agonist Sr 144528, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cb2+inverse+agonist+sr+144528/rabbit+anti+cb2r/pm40221089-196-23-30
    Average 90 stars, based on 1 article reviews
    cb2 inverse agonist sr 144528 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    sr-144528 (high affinity cb2 inverse agonist  (Cayman Chemical)
    90
    Cayman Chemical sr-144528 (high affinity cb2 inverse agonist
    Sr 144528 (High Affinity Cb2 Inverse Agonist, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cb2+inverse+agonist+sr+144528/SR+144528/pmc05322802-92-67-4
    Average 90 stars, based on 1 article reviews
    sr-144528 (high affinity cb2 inverse agonist - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    cb2 inverse agonist sr 144528  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology cb2 inverse agonist sr 144528
    Expression of cannabinoid and cannabinoid-like receptors in brain endothelial and melanoma cells. RT-PCR was performed to determine the expression of CB2A and CB2B (positive control: HL-60) transcriptional variants of human <t>CB2</t> receptor in hCMEC/D3 brain endothelial and A2058 melanoma cells ( a , b ); the expression of transcriptional variant 1 and 2 of rat CB2 receptor ( c , d ) in rat brain endothelial cells (RBECs) (positive control: rat spleen), the expression of CB1 receptor ( e ); transcriptional variant 1 and 2 of GPR18 ( f , g ); GPR119 ( h ) and GPR55 ( i ) in hCMEC/D3 human brain endothelial cells and A2058 melanoma cells. Dotted arrows indicate the absence of specific bands.
    Cb2 Inverse Agonist Sr 144528, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cb2+inverse+agonist+sr+144528/SR+144528/pmc04057719-97-2-14
    Average 90 stars, based on 1 article reviews
    cb2 inverse agonist sr 144528 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    cb2 receptor-specific inverse agonist sr 144528  (Sanofi)
    90
    Sanofi cb2 receptor-specific inverse agonist sr 144528
    Expression of cannabinoid and cannabinoid-like receptors in brain endothelial and melanoma cells. RT-PCR was performed to determine the expression of CB2A and CB2B (positive control: HL-60) transcriptional variants of human <t>CB2</t> receptor in hCMEC/D3 brain endothelial and A2058 melanoma cells ( a , b ); the expression of transcriptional variant 1 and 2 of rat CB2 receptor ( c , d ) in rat brain endothelial cells (RBECs) (positive control: rat spleen), the expression of CB1 receptor ( e ); transcriptional variant 1 and 2 of GPR18 ( f , g ); GPR119 ( h ) and GPR55 ( i ) in hCMEC/D3 human brain endothelial cells and A2058 melanoma cells. Dotted arrows indicate the absence of specific bands.
    Cb2 Receptor Specific Inverse Agonist Sr 144528, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cb2+inverse+agonist+sr+144528/cb2+receptor+antagonist+sr2/pm14764676-190-12-4
    Average 90 stars, based on 1 article reviews
    cb2 receptor-specific inverse agonist sr 144528 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Expression of cannabinoid and cannabinoid-like receptors in brain endothelial and melanoma cells. RT-PCR was performed to determine the expression of CB2A and CB2B (positive control: HL-60) transcriptional variants of human CB2 receptor in hCMEC/D3 brain endothelial and A2058 melanoma cells ( a , b ); the expression of transcriptional variant 1 and 2 of rat CB2 receptor ( c , d ) in rat brain endothelial cells (RBECs) (positive control: rat spleen), the expression of CB1 receptor ( e ); transcriptional variant 1 and 2 of GPR18 ( f , g ); GPR119 ( h ) and GPR55 ( i ) in hCMEC/D3 human brain endothelial cells and A2058 melanoma cells. Dotted arrows indicate the absence of specific bands.

    Journal: International Journal of Molecular Sciences

    Article Title: CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier

    doi: 10.3390/ijms15058063

    Figure Lengend Snippet: Expression of cannabinoid and cannabinoid-like receptors in brain endothelial and melanoma cells. RT-PCR was performed to determine the expression of CB2A and CB2B (positive control: HL-60) transcriptional variants of human CB2 receptor in hCMEC/D3 brain endothelial and A2058 melanoma cells ( a , b ); the expression of transcriptional variant 1 and 2 of rat CB2 receptor ( c , d ) in rat brain endothelial cells (RBECs) (positive control: rat spleen), the expression of CB1 receptor ( e ); transcriptional variant 1 and 2 of GPR18 ( f , g ); GPR119 ( h ) and GPR55 ( i ) in hCMEC/D3 human brain endothelial cells and A2058 melanoma cells. Dotted arrows indicate the absence of specific bands.

    Article Snippet: The selective CB2 inverse agonist SR-144528 (dissolved in ethanol) [ , ] was from Santa Cruz, the MEK1/2 inhibitor U0126 was from Cell Signaling and the Gi/Goα inhibitor pertussis toxin (PTX) was from Sigma-Aldrich (Budapest, Hungary).

    Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Positive Control, Variant Assay

    Effect of CB2 activation on the attachment of melanoma cells on the brain endothelium. Results are represented as % control ( i.e. , D3 + A2058) and given as mean ± SD. N = 3. * p < 0.05 as assessed by ANOVA and Bonferroni’s post-hoc test. ( a ) D3(jwh-133) and A2058(jwh-133) represent cells pre-treated with 10 μM JWH-133 for 4 h. D3 + A2058 + JWH-133 denotes cells treated with 10 μM JWH-133 during the 90 min adhesion assay; ( b ) JWH-133 (10 μM), U0126 (10 μM) and PTX (100 ng/mL) were applied in pre-treatment of both cell types and treatment during the adhesion assay.

    Journal: International Journal of Molecular Sciences

    Article Title: CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier

    doi: 10.3390/ijms15058063

    Figure Lengend Snippet: Effect of CB2 activation on the attachment of melanoma cells on the brain endothelium. Results are represented as % control ( i.e. , D3 + A2058) and given as mean ± SD. N = 3. * p < 0.05 as assessed by ANOVA and Bonferroni’s post-hoc test. ( a ) D3(jwh-133) and A2058(jwh-133) represent cells pre-treated with 10 μM JWH-133 for 4 h. D3 + A2058 + JWH-133 denotes cells treated with 10 μM JWH-133 during the 90 min adhesion assay; ( b ) JWH-133 (10 μM), U0126 (10 μM) and PTX (100 ng/mL) were applied in pre-treatment of both cell types and treatment during the adhesion assay.

    Article Snippet: The selective CB2 inverse agonist SR-144528 (dissolved in ethanol) [ , ] was from Santa Cruz, the MEK1/2 inhibitor U0126 was from Cell Signaling and the Gi/Goα inhibitor pertussis toxin (PTX) was from Sigma-Aldrich (Budapest, Hungary).

    Techniques: Activation Assay, Control, Cell Adhesion Assay

    Effect of CB2 activation on the transendothelial migration of melanoma cells. Results are represented as % control ( i.e. , RBEC + A2058) and given as mean ± SD. N = 3. * p < 0.01 (compared to control) as assessed by ANOVA and Bonferroni’s post-hoc test. ( a ) RBEC(jwh-133) represents endothelial cells pre-treated with 10 μM JWH-133 for 4 h. RBEC(jwh-133) + A2058(jwh-133) + JWH-133 denotes that both endothelial and melanoma cells were pre-treated with 10 μM JWH-133 for 4 h and treated with 10 μM JWH-133 during the 5 h transmigration assay; ( b ) JWH-133 (10 μM) and SR-144528 (10 μM) were applied in pre-treatment of both cell types and treatment during the transmigration assay.

    Journal: International Journal of Molecular Sciences

    Article Title: CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier

    doi: 10.3390/ijms15058063

    Figure Lengend Snippet: Effect of CB2 activation on the transendothelial migration of melanoma cells. Results are represented as % control ( i.e. , RBEC + A2058) and given as mean ± SD. N = 3. * p < 0.01 (compared to control) as assessed by ANOVA and Bonferroni’s post-hoc test. ( a ) RBEC(jwh-133) represents endothelial cells pre-treated with 10 μM JWH-133 for 4 h. RBEC(jwh-133) + A2058(jwh-133) + JWH-133 denotes that both endothelial and melanoma cells were pre-treated with 10 μM JWH-133 for 4 h and treated with 10 μM JWH-133 during the 5 h transmigration assay; ( b ) JWH-133 (10 μM) and SR-144528 (10 μM) were applied in pre-treatment of both cell types and treatment during the transmigration assay.

    Article Snippet: The selective CB2 inverse agonist SR-144528 (dissolved in ethanol) [ , ] was from Santa Cruz, the MEK1/2 inhibitor U0126 was from Cell Signaling and the Gi/Goα inhibitor pertussis toxin (PTX) was from Sigma-Aldrich (Budapest, Hungary).

    Techniques: Activation Assay, Migration, Control, Transmigration Assay